What Can Robotic Process Automation Mean for the Longevity of the Healthcare System?

 

In the current climate, healthcare systems are facing increased financial strain due to the ongoing effects of the pandemic. This reality, combined with the continuous pressure to reduce costs and improve efficiency, calls for innovative, solutions-oriented strategies that break away from traditional dependency models. The emerging role of Robotic Process Automation (RPA) and machine learning technologies provides a promising avenue to navigate these challenges, yet raises critical questions about necessary capital investments and the inherent variability of human labor. 

In chatting to “Highway to Health” at the HFMA 2023, Ryan O’Hara, DVP Consulting at Acclara, discusses advocating for a new paradigm that not only offers long-term, cost-effective solutions, but also aims to foster a healthier financial environment for healthcare systems, such as Robotic Process Automation.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…